Here you’ll find the latest news articles and updates from the ICBA and the Biotech Industrty.
For the future of innovation and, most importantly, for the benefit of patients and
citizens globally the International Council of Biotechnology Associations (ICBA) calls
for continued strengthening and expansion of trade, regulatory, and scientific
partnerships with global partners. Only through robust global cooperation can we
build a resilient, innovative, biopharmaceutical and biotechnology ecosystem that
benefits citizens everywhere.
Read Full Statement:
The International Council of Biotech Associations (ICBA) is pleased to announce the election of its new board chair and vice chair. Oliver Schacht, Chairman of Bio Deutschland and CEO of OpGen Inc, was elected to
Oliver Schacht, Chair of the International Council of Biotechnology Associations, released the following statement in response to a decision by the World Trade Organization (WTO) Ministerial Conference (MC12) to endorse a COVID-19 vaccine intellectual property waiver:
Steve Bates, Chair of ICBA said “Now that the text is open to public scrutiny after its formal proposal by the WTO Director-General, it is clear that what is proposed would do nothing to solve
Steve Bates Chair of ICBA said “The leaked QUAD proposal of a waiver on intellectual property rights for COVID vaccines would, if agreed, have a chilling impact on investment into the small companies that have
International Council of Biotechnology Associations
1201 New York Avenue NW Suite 1300
Washington, DC 20005
icba@bio.org
